Informationen:
Fehler:
ID
27501
Beschreibung
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?; ODM derived from: https://clinicaltrials.gov/show/NCT00430170
Link
https://clinicaltrials.gov/show/NCT00430170
Stichworte
Versionen (1)
- 19.11.17 19.11.17 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
19. November 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Cardiovascular Disease NCT00430170
Eligibility Cardiovascular Disease NCT00430170
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Cardiovascular Disease NCT00430170
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender
Item
male
boolean
C0079399 (UMLS CUI [1])
Age
Item
age between 18-50yr.
boolean
C0001779 (UMLS CUI [1])
Cardiovascular Disease
Item
cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Hypertensive disease | Systolic Pressure | Diastolic blood pressure
Item
hypertension (systole > 140 mmhg, diastole > 90 mmhg)
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Hypercholesterolemia | Serum total cholesterol measurement Random
Item
hypercholesterolemia (random total cholesterol > 6.5 mmol/l)
boolean
C0020443 (UMLS CUI [1])
C1445957 (UMLS CUI [2,1])
C0439605 (UMLS CUI [2,2])
C1445957 (UMLS CUI [2,1])
C0439605 (UMLS CUI [2,2])
Diabetes Mellitus | Serum fasting glucose measurement | Serum random glucose measurement
Item
diabetes mellitus (fasting glucose > 7.0 mmol/l or random glucose > 11.0 mmol/l)
boolean
C0011849 (UMLS CUI [1])
C0583334 (UMLS CUI [2])
C0583333 (UMLS CUI [3])
C0583334 (UMLS CUI [2])
C0583333 (UMLS CUI [3])
Asthma | Dyspnea Recurrent episode | Wheezing Recurrent episode | Inhalation Drug Administration prescribed | Adrenal Cortex Hormones | beta2-Adrenergic Agonist
Item
asthma (recurrent episodes of dyspnea and wheezing, or usage of prescribed inhalation medication: i.e. corticosteroids or b2-agonists)
boolean
C0004096 (UMLS CUI [1])
C0013404 (UMLS CUI [2,1])
C0443287 (UMLS CUI [2,2])
C0043144 (UMLS CUI [3,1])
C0443287 (UMLS CUI [3,2])
C0001559 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
C0001617 (UMLS CUI [5])
C2917450 (UMLS CUI [6])
C0013404 (UMLS CUI [2,1])
C0443287 (UMLS CUI [2,2])
C0043144 (UMLS CUI [3,1])
C0443287 (UMLS CUI [3,2])
C0001559 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
C0001617 (UMLS CUI [5])
C2917450 (UMLS CUI [6])
Study Subject Participation Status
Item
participation in any clinical trial during the last 60 days prior to this study.
boolean
C2348568 (UMLS CUI [1])
Annexin A5 Dose Quantity
Item
administration of two doses of annexin a5 (0,1mg; 450mbq) during the last 5 years prior to this study.
boolean
C0059249 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])